Antiangiogenic Therapy for Diabetic Nephropathy

Angiogenesis has been shown to be a potential therapeutic target for early stages of diabetic nephropathy in a number of animal experiments. Vascular endothelial growth factor (VEGF) is the main mediator for abnormal angiogenesis in diabetic glomeruli. Although beneficial effects of anti-VEGF antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanabe, Katsuyuki, Maeshima, Yohei, Sato, Yasufumi, Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556994/
https://www.ncbi.nlm.nih.gov/pubmed/28835895
http://dx.doi.org/10.1155/2017/5724069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556994/
https://www.ncbi.nlm.nih.gov/pubmed/28835895
http://dx.doi.org/10.1155/2017/5724069

Ejemplares similares